Suchergebnisse

PubPharm (124)

1

Venetoclax-based salvage in multiple myeloma with (11;14) translocation after suboptimal response to first-line therapy

enthalten in: Orvosi hetilap | 2023

von Szita, V. | Wiedemann, �. | Syoreni, S. | +5

2

Oncodiabetology III. The relationship of antineoplastic therapies and carbohydrate metabolism

enthalten in: Orvosi hetilap | 2022

von Bánhegyi, R. | Veréb, B. | Gazdag, A. | +4

3

New aspects of chemotherapy and indications for maintenance immunotherapy in urothelial cancers

enthalten in: Magyar onkologia | 2021

von Maráz, A. | Varga, L. | Pósfai, B. | +2

4

Skeletal-related side effects of acute lymphoblastic leukemia treatment in children

enthalten in: Orvosi hetilap | 2020

von Beniczky, N. | Hosszú, �. | Erdélyi, D. | +3

5

Oncorheumatology : relationship between malignancies and musculoskeletal diseases

enthalten in: Orvosi hetilap | 2020

von Szekanecz, Z. | Gomez, I. | Soós, B. | +15

6

Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer

enthalten in: Orvosi hetilap | 2020

von Szarvas, T. | Csizmarik, A. | Nagy, N. | +5

7

Optimization of peptide-drug conjugates for targeted tumor therapy

enthalten in: Magyar onkologia | 2019

von Mezõ, G. | Biri-Kovács, B. | Pethõ, L. | +5

8

Comparison of therapeutic peptides targeting pancreatic cancer

enthalten in: Magyar onkologia | 2019

von Mezõ, G. | Dókus, L. | Schlosser, G. | +6

9

Molecular subtype classification of urothelial bladder cancer and its clinical relevance

enthalten in: Orvosi hetilap | 2019

von Szarvas, T. | Oláh, C. | Riesz, P. | +2

10

Benefits of combining chemotherapy with immuno- oncology therapies or "Is it true that chemotherapy destroys the immune system?"

enthalten in: Magyar onkologia | 2019

von Kocsis, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]